In a newly planned trial, recently approved by the FDA, researchers will examine whether stem cells obtained through umbilical cord blood at birth may be an effective treatment for children with autism. The 30 children that will participate in the placebo controlled trial, ages 2-7, had umbilical cord blood banked at birth, as part of the Cord Blood Registry, a highly organized and well known stem cell bank.
